Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lipponen

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Apoptosis in breast cancer as related to histopathological characteristics and prognosisP Lipponen, S Aaltomaa, V M Kosma, et al.
Anticancer Research|May 1, 1993
Mast cells in breast cancerS Aaltomaa, P Lipponen, S Papinaho, et al.
Anticancer Research|March 1, 1994
Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinomaS Vesalainen, P Lipponen, M Talja, et al.
Anticancer Research|May 6, 1998
Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinomaK Mäkinen, T Hakala, P Lipponen, et al.
The Journal of Pathology|October 1, 1994
Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancerP Lipponen, E Saarelainen, H Ji, et al.
The European Journal of Surgery = Acta Chirurgica|May 1, 1991
Nuclear morphometry and mitotic indexes as prognostic factors in breast cancerS Aaltomaa, P Lipponen, M Eskelinen, et al.
International Journal of Cancer|August 19, 1993
p53 protein expression in breast cancer as related to histopathological characteristics and prognosisP Lipponen, H Ji, S Aaltomaa, et al.
Anticancer Research|November 1, 1993
Expression of tumour associated antigens 12H12, 2E11, 7A9, CEA and DF3 in human breast cancerM Eskelinen, P Lipponen, M Hippeläinen, et al.
British Journal of Cancer|August 1, 1994
Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidyS Vesalainen, S Nordling, P Lipponen, et al.
European Urology|January 1, 1991
Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladderP Lipponen, M Eskelinen, S Syrjänen, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Apoptosis in breast cancer as related to histopathological characteristics and prognosisP Lipponen, S Aaltomaa, V M Kosma, et al.
Anticancer Research|May 1, 1993
Mast cells in breast cancerS Aaltomaa, P Lipponen, S Papinaho, et al.
Anticancer Research|March 1, 1994
Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinomaS Vesalainen, P Lipponen, M Talja, et al.
Anticancer Research|May 6, 1998
Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinomaK Mäkinen, T Hakala, P Lipponen, et al.
The Journal of Pathology|October 1, 1994
Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancerP Lipponen, E Saarelainen, H Ji, et al.
The European Journal of Surgery = Acta Chirurgica|May 1, 1991
Nuclear morphometry and mitotic indexes as prognostic factors in breast cancerS Aaltomaa, P Lipponen, M Eskelinen, et al.
International Journal of Cancer|August 19, 1993
p53 protein expression in breast cancer as related to histopathological characteristics and prognosisP Lipponen, H Ji, S Aaltomaa, et al.
Anticancer Research|November 1, 1993
Expression of tumour associated antigens 12H12, 2E11, 7A9, CEA and DF3 in human breast cancerM Eskelinen, P Lipponen, M Hippeläinen, et al.
British Journal of Cancer|August 1, 1994
Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidyS Vesalainen, S Nordling, P Lipponen, et al.
European Urology|January 1, 1991
Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladderP Lipponen, M Eskelinen, S Syrjänen, et al.
Pageof 13